TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Otsuka Pharma Scandinavia AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
31,986
|
30,178
|
28,909 |
| Financial expenses |
1
|
0
|
3 |
| Earnings before taxes |
905
|
821
|
1,058 |
| EBITDA |
891
|
800
|
1,091 |
| Total assets |
11,876
|
11,890
|
10,903 |
| Current assets |
11,841
|
11,828
|
10,857 |
| Current liabilities |
7,532
|
7,472
|
6,300 |
| Equity capital |
4,344
|
4,417
|
4,603 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
39
|
38
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.6%
|
37.1%
|
42.2% |
| Turnover per employee |
820
|
794
|
826 |
| Profit as a percentage of turnover |
2.8%
|
2.7%
|
3.7% |
| Return on assets (ROA) |
7.6%
|
6.9%
|
9.7% |
| Current ratio |
157.2%
|
158.3%
|
172.3% |
| Return on equity (ROE) |
20.8%
|
18.6%
|
23.0% |
| Change turnover |
2,833
|
1,185
|
3,293 |
| Change turnover % |
10%
|
4%
|
13% |
| Chg. No. of employees |
1
|
3
|
-1 |
| Chg. No. of employees % |
3%
|
9%
|
-3% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.